I wonder why we are optimistic about the pivotal study started early next year? Which will be held in US, Europe and Aus.
The reason we have difficulty in recruiting participants was, according to some posters here, our study/trial does not help the patients sickness, they have been through a lot, there is no reason why they would join this trial.
Then why those patients overseas will participate this coming trial?
Imagion Biosystems (ASX:IBX): Big things come in nano packages, page-140
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
